BLUE bluebird bio

SVB Leerink Lowers Bluebird Bio (NASDAQ:BLUE) Price Target to $8.00

bluebird bio (NASDAQ:BLUE – Get Rating) had its price target reduced by SVB Leerink from $9.00 to $8.00 in a research note issued to investors on Monday, Benzinga reports. They currently have a marke

01-27 16:08

SVB Leerink Cuts Bluebird Bio (NASDAQ:BLUE) Price Target to $8.00

bluebird bio (NASDAQ:BLUE – Get Rating) had its target price trimmed by SVB Leerink from $9.00 to $8.00 in a report published on Monday morning, Benzinga reports. The brokerage currently has a market

01-26 17:37

Bluebird Bio (NASDAQ:BLUE) Shares Up 5.5% on Analyst Upgrade

Shares of bluebird bio, Inc. (NASDAQ:BLUE – Get Rating) were up 5.5% during mid-day trading on Tuesday after Morgan Stanley raised their price target on the stock from $3.00 to $4.00. Morgan Stanley

01-25 17:01

Q1 2023 Earnings Estimate for Bluebird Bio, Inc. Issued By SVB Leerink (NASDAQ:BLUE)

bluebird bio, Inc. (NASDAQ:BLUE – Get Rating) – Equities researchers at SVB Leerink issued their Q1 2023 earnings per share estimates for shares of bluebird bio in a research report issued on Mond

01-25 15:51

What 4 Analyst Ratings Have To Say About Bluebird Bio

bluebird bio (NASDAQ:BLUE) has observed the following analyst ratings within the last quarter: BullishSomewhat BullishIndifferentSomewhat BearishBearishTotal Ratings00310Last 30D000101M Ago002002M Ago

01-25 04:02

Zacks.com Featured Highlights Include Bluebird Bio, Pros Holdings and Norwegian Cruise Line

01-25 00:42

Bluebird Bio (BLUE) Receives a Sell From Morgan Stanley

01-25 00:30

Morgan Stanley Adjusts Price Target on Bluebird Bio to $4 From $3, Maintains Underweight Rating

09:05 AM EST, 01/24/2023 (MT Newswires) -- bluebird bio (BLUE) has an average hold rating and a price target range of $4 to $10, according to analysts polled by Capital IQ.

01-24 22:06

Bluebird Bio Price Target Raised to $4.00/Share From $3.00 by Morgan Stanley

Bluebird Bio Price Target Raised to $4.00/Share From $3.00 by Morgan Stanley

01-24 21:48

Bluebird Bio Is Maintained at Underweight by Morgan Stanley

Bluebird Bio Is Maintained at Underweight by Morgan Stanley

01-24 21:47